Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation: a Multicenter Randomized Controlled Trial
Phase of Trial: Phase III
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacodynamics
- Acronyms EFFECT-KTx
- 04 Sep 2019 Planned End Date changed from 1 Jan 2022 to 1 Jan 2023.
- 04 Sep 2019 Planned primary completion date changed from 1 Jan 2022 to 1 Jan 2023.
- 04 Sep 2019 Status changed from not yet recruiting to recruiting.